Loading...
menu
Search
AI Chat
AI Strategies
Products
Markets
News
Resources
Pricing
Home
ETF
MRK
MRK
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
MRK News
Institutional Managers Anticipate Market Correction in 2026
1d ago
Fool
Growth Stocks Decline, Value Stocks Poised for Opportunity
1d ago
Fool
Ongoing Shakeup at HHS with Deputy Secretary Departure
2d ago
seekingalpha
Eli Lilly Acquires Orna Therapeutics to Expand Drug Pipeline
2d ago
Fool
Latest Wall Street Rating Updates
2d ago
CNBC
Deutsche Bank Upgrades Merck to Buy with $150 Target
2d ago
Yahoo Finance
Analysis of VONE Stock Performance
3d ago
NASDAQ.COM
Growth Prospects for the EGFR-NSCLC Market Analyzed
3d ago
Newsfilter
FDA Approves Merck's Keytruda for Ovarian Cancer Treatment
4d ago
Benzinga
Merck's KEYTRUDA Approved by FDA for Ovarian Cancer Treatment
4d ago
Businesswire
FDA Approves Merck's Keytruda for Ovarian Cancer Treatment
4d ago
seekingalpha
Analyst Activity: Tesla and CrowdStrike Upgraded Amid Market Shifts
5d ago
seekingalpha
Tech Stocks Surge as AI Drives Market Recovery
5d ago
Fool
Eli Lilly's Stock Increases as It Purchases Cell Therapy Firm for $2.4 Billion.
6d ago
Barron's
Investor Confusion in AI Competition
6d ago
CNBC
Dividend Stocks Gain Appeal Amid Tech Stock Meltdown
Feb 08 2026
Fool
Show More News
